The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRH Regulatory News (CRH)

Share Price Information for CRH (CRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,250.00
Bid: 6,252.00
Ask: 6,258.00
Change: -44.00 (-0.70%)
Spread: 6.00 (0.096%)
Open: 6,316.00
High: 6,332.00
Low: 6,214.00
Prev. Close: 6,294.00
CRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Development Strategy Update

1 Mar 2017 07:00

RNS Number : 1065Y
CRH PLC
01 March 2017
 

01 March 2017

Development Strategy Update

CRH announces 2017 year-to-dateacquisition and investment spend of c.€500 million

and disposals totalling c.€400 million

 

CRH plc, the international building materials group, announces 2017 year-to-date acquisition and investment spend of approximately €500 million reflecting eight transactions. In addition, the Group has reached agreement to divest six businesses which will result in total proceeds of approximately €400 million.

Commenting on these developments, Albert Manifold, CRH Chief Executive, said:

"CRH's development activity in the first two months of 2017 demonstrates both our strong pipeline and our commitment to value-accretive portfolio management. With the disposal transactions announced today, proceeds from divestments since 2014 will have reached €2 billion, and the Group continues to reinvest these proceeds to strengthen our core existing businesses and expand our operations."

 

Acquisitions - c.€500 million

Development activity in the first two months of 2017 comprised seven acquisitions spread across each of our four Americas Materials divisions (North, South, Central and West) and also CRH Canada. In addition, one small investment transaction was completed by our Americas Products Division.

South (1): The principal acquisition completed to date in 2017 is that of Mulzer Crushed Stone, Inc.. Mulzer is one of the largest privately held aggregates producers in the United States and operates six quarries, five sand and gravel operations, fourteen aggregates yards, four readymixed concrete plants and three asphalt plants, serving the Ohio and Kanawha river valleys.

Central (2): Two acquisitions in the greater Minneapolis/St. Paul region, Hardrives Inc. and Chard Tiling and Excavating, strengthen our aggregates-based vertical integration strategy in this region and also increase and diversify our exposure to residential and commercial/industrial segments. These acquisitions add two aggregates operations, eight asphalt plants, asphalt construction and an asphalt terminal operation and will provide immediate synergies as we integrate these businesses with our existing aggregates and asphalt business in southern Minnesota.

West (2): Columbia Asphalt, a vertically integrated business in Yakima, Washington, with three aggregates sites, three asphalt plants and one readymixed concrete plant was acquired. We also purchased certain assets of Connell Resources, a vertically integrated aggregates, asphalt, and construction company with operations in Colorado.

North (1): The acquisition of Costello Industries Inc., a leading cold milling contractor in Connecticut, will provide synergies with our existing asphalt production and paving business in the region.

Canada (1): The acquisition of certain quarry assets in the Greater Montreal Area significantly strengthens our position in the concrete stone market by adding c.100mt of licensed reserves as well as securing long-term concrete stone supply for our vertically integrated readymixed concrete business.

The Oldcastle BuildingEnvelope® business of Americas Products completed a small investment in January 2017.

 

Divestments - c.€400 million 

In line with our continued focus on portfolio management, our Europe Heavyside Division has reached agreement on six divestments to date in 2017 for total proceeds of approximately €400 million.

Germany: In the largest disposal transaction so far this year, CRH has reached agreement to divest one cement plant and one grinding station in Germany; these assets formed part of the LH Assets acquisition in 2015. The transaction is subject to approval by the German Competition Authority (Bundeskartellamt).

Netherlands, Belgium, Germany: Two years ago, CRH sold its clay and concrete businesses in the United Kingdom and its clay business in the United States. At the end of January 2017, the majority of CRH's remaining clay products businesses in Europe were divested.

Benelux: In January 2017, Europe Heavyside sold its non-core civil prefabricated concrete businesses in the Benelux.

France, Germany and Switzerland: Three further smaller divestments have taken place in France, Germany and Switzerland in the first two months of 2017.

 

Contact at Dublin +353 1 404 1000

Frank Heisterkamp Head of Investor Relations

 

About CRH

CRH (LSE: CRH, ISE: CRG, NYSE: CRH) is a leading global diversified building materials group, employing c.87,000 people at c.3,800 operating locations in 31 countries worldwide. With a market capitalisation of c.€26 billion (March 2017), CRH is the largest building materials company in North America and the second largest worldwide. The Group has leadership positions in Europe as well as established strategic positions in the emerging economic regions of Asia and South America. CRH is committed to improving the built environment through the delivery of superior materials and products for the construction and maintenance of infrastructure, housing and commercial projects. A Fortune 500 company, CRH is a constituent member of the FTSE 100 index, the EURO STOXX 50 index and the ISEQ 20. CRH's American Depositary Shares are listed on the NYSE.

For more information visit www.crh.com

 

Registered Office: No 12965. Registered Office: 42 Fitzwilliam Square, Dublin 2, D02 R279, Ireland.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSEFTITFID
Date   Source Headline
4th Apr 20244:15 pmRNSTransaction in Own Shares
2nd Apr 20244:10 pmRNSBlock listing Interim Review
2nd Apr 20243:08 pmRNSTotal Voting Rights
27th Mar 20245:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:30 pmRNSDirector/PDMR Shareholding
20th Mar 20249:30 amRNSTransaction in Own Shares
19th Mar 20249:40 amRNSTransaction in Own Shares
19th Mar 20249:15 amRNSTransaction in Own Shares
15th Mar 20243:15 pmRNSNotice of AGM
15th Mar 20249:30 amRNSTransaction in Own Shares
14th Mar 20249:30 amRNSTransaction in Own Shares
13th Mar 20249:30 amRNSTransaction in Own Shares
12th Mar 20249:15 amRNSTransaction in Own Shares
11th Mar 20249:30 amRNSTransaction in Own Shares
8th Mar 20245:00 pmRNSDirector/PDMR Shareholding
8th Mar 20249:30 amRNSTransaction in Own Shares
7th Mar 20249:30 amRNSTransaction in Own Shares
6th Mar 20248:45 amRNSTransaction in Own Shares
5th Mar 20245:30 pmRNSDirector/PDMR Shareholding
5th Mar 20249:45 amRNSTransaction in Own Shares
4th Mar 20244:00 pmRNSTransaction in Own Shares
4th Mar 20249:45 amRNSTransaction in Own Shares
1st Mar 20243:00 pmRNSTransaction in Own Shares
29th Feb 20243:00 pmRNSTotal Voting Rights
29th Feb 202412:05 pmRNS2023 Annual Report on Form 10-K
29th Feb 20248:45 amRNSTransaction in Own Shares
28th Feb 20249:30 amRNSTransaction in Own Shares
27th Feb 20249:30 amRNSTransaction in Own Shares
26th Feb 20249:30 amRNSTransaction in Own Shares
23rd Feb 20249:30 amRNSTransaction in Own Shares
23rd Feb 20247:05 amRNS5% Preference Shares - Listings Update
22nd Feb 20249:30 amRNSTransaction in Own Shares
21st Feb 20249:30 amRNSTransaction in Own Shares
21st Feb 20247:05 amRNS5% Preference Shares - Listings Update
19th Feb 20249:30 amRNSTransaction in Own Shares
16th Feb 20249:30 amRNSTransaction in Own Shares
15th Feb 20249:30 amRNSTransaction in Own Shares
14th Feb 20249:30 amRNSTransaction in Own Shares
9th Feb 20249:30 amRNSTransaction in Own Shares
8th Feb 20249:30 amRNSTransaction in Own Shares
7th Feb 20243:00 pmRNSTransaction in Own Shares
7th Feb 20249:30 amRNSTransaction in Own Shares
6th Feb 20249:15 amRNSTransaction in Own Shares
5th Feb 202412:30 pmRNSTransaction in Own Shares
2nd Feb 20249:30 amRNSTransaction in Own Shares
1st Feb 20249:00 amRNSTransaction in Own Shares
31st Jan 20242:30 pmRNSTotal Voting Rights
31st Jan 20249:30 amRNSTransaction in Own Shares
30th Jan 20249:30 amRNSTransaction in Own Shares
26th Jan 20243:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.